The impact of IL28B gene polymorphisms on drug responses
The impact of IL28B gene polymorphisms on drug responses
In particular, the IL28B gene polymorphisms have been studied and shown to have impacts on drug responses in the treatment of many diseases, such as chronic hepatitis C, chronic hepatitis B, and myeloproliferative neoplasms.